Differing cytotoxicity and bioavailability of selenite, methylselenocysteine, selenomethionine, selenosugar 1 and trimethylselenonium ion and their underlying metabolic transformations in human cells

Molecular Nutrition and Food Research

Volumn 60, Issue 12, 2016, Pages 2622-2632

  Marschall, Talke Anu ^a   Bornhorst, Julia ^a   Kuehnelt, Doris ^b   Schwerdtle, Tanja ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cellular bioavailability; ICP QQQ MS; Selenosugar 1; Small selenium species; Speciation

Indexed keywords

SELENIOUS ACID; SELENIUM DERIVATIVE; SELENOCYSTEINE; SELENOMETHIONINE; SELENOMETHYLSELENOCYSTEINE; TRIMETHYLSELENONIUM;

ANALOGS AND DERIVATIVES; BIOAVAILABILITY; CYTOLOGY; DRUG EFFECTS; GLIA; HEP-G2 CELL LINE; HUMAN; LIMIT OF DETECTION; METABOLISM; TUMOR CELL LINE; UROTHELIUM;

BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; HEP G2 CELLS; HUMANS; LIMIT OF DETECTION; NEUROGLIA; SELENIOUS ACID; SELENIUM COMPOUNDS; SELENOCYSTEINE; SELENOMETHIONINE; UROTHELIUM;

EID: 84987623978     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600422     Document Type: Article

References (46)

1. Rayman, M. P., Selenium and human health. Lancet 2012, 379, 1256–1268.
2. Hatfield, D. L., Tsuji, P. A., Carlson, B. A., Gladyshev, V. N., Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem. Sci. 2014, 39, 112–120.
3. European Commission, Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Selenium. 2000.
4. U.S. Department for Health and Human Services, Toxicological Profile for Selenium. 2003.
5. Misra, S., Boylan, M., Selvam, A., Spallholz, J. E. et al., Redox-active selenium compounds-from toxicity and cell death to cancer treatment. Nutrients 2015, 7, 3536–3556.
6. Wrobel, J. K., Power, R., Toborek, M., Biological activity of selenium: Revisited. IUBMB Life 2016, 68, 97–105.
7. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S. et al., Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). J. Am. Med. Assoc. 2009, 301, 39–51.
8. Kristal, A. R., Darke, A. K., Morris, J. S., Tangen, C. M. et al., Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J. Natl. Cancer Inst. 2014, 106, 1–8.
9. Jablonska, E., Vinceti, M., Selenium and human health: witnessing a copernican revolution? J. Environ. Sci. Health C 2015, 33, 328–368.
10. Gammelgaard, B., Jackson, M. I., Gabel-Jensen, C., Surveying selenium speciation from soil to cell-forms and transformations. Anal. Bioanal. Chem. 2011, 399, 1743–1763.
11. Weekley, C. M., Harris, H. H., Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem. Soc. Rev. 2013, 42, 8870–8894.
12. Jäger, T., Drexler, H., Göen, T., Human metabolism and renal excretion of selenium compounds after oral ingestion of sodium selenite and selenized yeast dependent on the trimethylselenium ion (TMSe) status. Arch. Toxicol. 2015, 28, 1402–1409.
13. Kuehnelt, D., Engström, K., Skröder, H., Kokarnig, S. et al., Selenium metabolism to the trimethylselenonium ion (TMSe) varies markedly because of polymorphisms in the indolethylamine. Am. Clin. Nutr. 2015, 102, 1406–1415.
14. Kuehnelt, D., Kienzl, N., Traar, P., Le, N. H. et al., Selenium metabolites in human urine after ingestion of selenite, L-selenomethionine, or DL-selenomethionine: a quantitative case study by HPLC/ICPMS. Anal. Bioanal. Chem. 2005, 383, 235–246.
15. Obermeyer, B. D., Palmer, I. S., Olson, O. E., Halverson, A. W., Toxicity of trimethylselenonium chloride in the rat with and without arsenite. Toxicol. Appl. Pharmacol. 1971, 20, 135–146.
16. Palmer, I. S., Arnold, R. L., Carlson, C. W., Toxicity of various selenium derivatives to chick embryos. Poult. Sci. 1973, 52, 1841–1846.
17. Ip, C., Ganther, H., Biological activities of trimethylselenonium as influenced by arsenite. J. Inorg. Biochem. 1992, 46, 215–222.
18. Olson, O. E., Selenium toxicity in animals with emphasis on man. Int. J. Toxicol. 1986, 5, 45–70.
19. Kokarnig, S., Tsirigotaki, A., Wiesenhofer, T., Lackner, V. et al., Concurrent quantitative HPLC-mass spectrometry profiling of small selenium species in human serum and urine after ingestion of selenium supplements. J. Trace Elem. Med. Biol. 2014, 29, 83–90.
20. Lunøe, K., Gabel-Jensen, C., Stürup, S., Andresen, L. et al., Investigation of the selenium metabolism in cancer cell lines. Metallomics 2011, 3, 162–168.
21. Kato, T., Read, R., Rozga, J., Burk, R. F., Evidence for intestinal release of absorbed selenium in a form with high hepatic extraction. Am. J. Physiol. 1992, 262, 854–858.
22. Wolffram, S., Berger, B., Grenacher, B., Scharrer, E., Transport of selenoamino acids and their sulfur analogues across the intestinal brush border membrane of pigs. J. Nutr. 1989, 89, 706–712.
23. Goossens, J., Vanhaecke, F., Moens, L., Dams, R., Elimination of interferences in the determination of arsenic and selenium in biological samples by inductively coupled plasma mass spectrometry. Anal. Chim. Acta 1993, 280, 137–143.
24. D'Ilio, S., Violante, N., Majorani, C., Petrucci, F., Dynamic reaction cell ICP-MS for determination of total As, Cr, Se and V in complex matrices: Still a challenge? A review. Anal. Chim. Acta 2011, 698, 6–13.
25. Gammelgaard, B., Jøns, O., Determination of selenium in urine by inductively coupled plasma mass spectrometry: interferences and optimization. J. Anal. At. Spectrom. 1999, 14, 867–874.
26. Bolea-Fernandez, E., Balcaen, L., Resano, M., Vanhaecke, F., Interference-free determination of ultra-trace concentrations of arsenic and selenium using methyl fluoride as a reaction gas in ICP–MS/MS. Anal. Bioanal. Chem. 2015, 407, 919–929.
27. Traar, P., Belaj, F., Francesconi, K. A., Synthesis of methyl 2-acetamido-2-deoxy-1-seleno-β-d-gluco- and galacto-pyranoside: Selenium metabolites in human urine. Aust. J. Chem. 2004, 57, 1051–1053.
28. Hoffman, J. L., Ion chromatographic analysis of the purity and synthesis of sulfonium and selenonium ions. J. Chromatogr. A 1991, 588, 211–216.
29. Juresa, D., Darrouzès, J., Kienzl, N., Bueno, M. et al., An HPLC/ICPMS study of the stability of selenosugars in human urine: implications for quantification, sample handling, and storage. J. Anal. At. Spectrom. 2006, 21, 684–690.
30. Ebert, F., Weiss, A., Bültemeyer, M., Hamann, I. et al., Arsenicals affect base excision repair by several mechanisms. Mutat. Res. 2011, 715, 32–41.
31. Lohren, H., Bornhorst, J., Fitkau, R., Pohl, G. et al., Effects on and transfer across the blood-brain barrier in vitro - Comparison of organic and inorganic mercury species. Neurometals 2015, 90, 1069–1080.
32. O'Brien, J., Wilson, I., Orton, T., Pognan, F., Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421–5426.
33. Kokarnig, S., Kuehnelt, D., Stiboller, M., Hartleb, U. et al., Quantitative determination of small selenium species in human serum by HPLC/ICPMS following a protein-removal, pre-concentration procedure. Anal. Bioanal. Chem. 2011, 400, 2323–2327.
34. Jackson, B., Liba, A., Nelson, J., Advantages of reaction cell ICP-MS on doubly charged interferences for arsenic and selenium analysis in foods. J. Anal. At. Spectrom. 2015, 30, 1179–1183.
35. Sucharová, J., Optimisation of DRC ICP-MS for determining selenium in plants. J. Anal. At. Spectrom. 2011, 26, 1756–1762.
36. Flores Villavicencio, L. L., Cruz-Jiménez, G., Barbosa-Sabanero, G., Kornhauser-Araujo, C. et al., Human lung cancer cell line A-549 ATCC is differentially affected by supranutritional organic and inorganic selenium. Bioinorg. Chem. Appl. 2014, 2014, 923834.
37. Ammar, E., Couri, D., Acute toxicity of sodium selenite and selenomethionine in mice after ICV or IV administration. Neurotoxicology 1981, 2, 383–386.
38. Hoefig, C. S., Renko, K., Köhrle, J., Birringer, M. et al., Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture. J. Nutr. Biochem. 2011, 22, 945–955.
39. Kipp, A. P., Frombach, J., Deubel, S., Brigelius-Flohé, R., Selenoprotein w as biomarker for the efficacy of selenium compounds to act as source for selenoprotein biosynthesis. Methods Enzymol. 2013, 527, 87–112.
40. Byard, J., Trimethyl a urinary metabolite of selenite. Arch. Biochem. Biophys. 1969, 130, 556–560.
41. Rayman, M. P., Infante, H. G., Sargent, M., Food-chain selenium and human health: spotlight on speciation. Br. J. Nutr. 2008, 100, 238–253.
42. Juresa, D., Blanusa, M., Francesconi, K. A., Kienzl, N. et al., Biological availability of selenosugars in rats. Chem. Biol. Interact. 2007, 168, 203–210.
43. Suzuki, K. T., Doi, C., Suzuki, N., Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite. Toxicol. Appl. Pharmacol. 2006, 217, 185–195.
44. Gabel-Jensen, C., Gammelgaard, B., Selenium metabolism in hepatocytes incubated with selenite, selenate, selenomethionine, Se-methylselenocysteine and methylseleninc acid and analysed by LC-ICP-MS. J. Anal. At. Spectrom. 2010, 25, 414–418.
45. Cuello, S., Ramos, S., Mateos, R., Martín, M. A. et al., Selenium methylselenocysteine protects human hepatoma HepG2 cells against oxidative stress induced by tert-butyl hydroperoxide. Anal. Bioanal. Chem. 2007, 389, 2167–2178.
46. Suzuki, K. T., Somekawa, L., Suzuki, N., Distribution and reuse of 76Se-selenosugar in selenium-deficient rats. Toxicol. Appl. Pharmacol. 2006, 216, 303–308.